Lindbrook Capital, LLC Sio Gene Therapies Inc. Transaction History

Lindbrook Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 27, 2021	SELL	$2.07 - $2.89 $18,834 - $26,296	-9,099 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$2.34 - $3.44 $11,700 - $17,200	5,000 Added 121.98%	9,099 $24,000
Q4 2020 Jan 27, 2021	BUY	$1.91 - $5.63 $7,829 - $23,077	4,099 New	4,099 $11,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.